SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (10687)7/7/1998 9:31:00 PM
From: blankmind  Read Replies (1) | Respond to of 23519
 
VLAD, I'm glad for you & some of the other ardent VVUS supporters that the stock has turned the corner.

- To get past all the hype, here's why Vivus is moving higher:

1. $40+ mill in the bank
2. FDA plant approval
3. #2 ED drug
4. Rolling out drug to 30 new countries
5. Projected to turn around in 3rd 1/4 & do $1+ in profit in '99; $2.50 in 2000.
6. 13+ mill short position - which has to be covered at some point.
7. Dissident shareholder movement to put VVUS on aution block for $40.
8. Need I say more?



To: VLAD who wrote (10687)7/8/1998 2:32:00 AM
From: betty moyers  Read Replies (2) | Respond to of 23519
 
Vlad, Do we turn on the seatbelt sign yet?